MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
PR Newswire

News of the day

Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation

20th November 2009 STOCKHOLM, November 20 /PRNewswire/ -- Karolinska Development AB today announced that the European Investment Fund (EIF) has entered into a co-investment agreement with the company. The co-investment fund will be managed by Karolinska Development and used to invest in the company's portfolio of early-stage pharmaceutical and medical technology companies. EIF has agreed to invest 26.7 M Euros in the co-investment fund. The agreement represents EIF's largest single investment in the Nordic region... more

New Consortium Paves the way for Improved Treatment of Hypertension and Associated Vascular Complications

17th November 2009 LEIDEN, The Netherlands, November 17 /PRNewswire/ -- Top Institute Pharma (TI Pharma) has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke. Based on novel action mechanisms, new drugs may be discovered with the potential to prevent vascular complications in... more

GSMA and the University of Manchester to Establish an m-Health Innovation Centre

11th November 2009 LONDON, November 11 /PRNewswire/ -- The GSMA, which represents the interests of the worldwide mobile communications industry, today announced that it has signed a Memorandum of Understanding with the University of Manchester to establish an m-Health Innovation Centre in Manchester, which will act as a UK focus for m-Health activity. The goal of the GSMA's m-Health initiative is to foster innovative mobile applications and services in healthcare that will focus on promoting healthier lifestyles... more
Joint Ventures RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
 

Category

To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Browse by category

More recent news

See the Benefits of a Healthy Lifestyle
9th November 2009 ANDOVER, England, November 9 /PRNewswire/ -- Sight charity The Eyecare Trust has joined forces with healthcare provider Simplyhealth to warn that many lifestyle choices can pose a serious threat to...

Bicycle Therapeutics and Pepscan Enter Into Partnership to Apply Constrained Peptide Technology in the Development of Novel Biotherapeutics
2nd November 2009 CAMBRIDGE, England and LELYSTAD, The Netherlands, November 2 /PRNewswire/ -- Bicycle Therapeutics has obtained a global license from Pepscan to utilize its proprietary constrained peptide chemistry...

Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
2nd November 2009 NEW BRUNSWICK, New Jersey, November 2 /PRNewswire/ -- In a joint statement, Czura Thornton's founders Tony Czura and Nick Thornton said: "We are delighted to augment our Life Sciences Group...

Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
2nd November 2009 COPENHAGEN, November 2 /PRNewswire/ -- Nuevolution A/S today announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc., Whitehouse Station, NJ. The...

InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways
2nd November 2009 UTRECHT, The Netherlands, November 2 /PRNewswire/ -- InteRNA Technologies B.V. and the Dana-Farber Cancer Institute (Boston, USA) have entered into a research agreement to develop microRNA...

London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
30th October 2009 LONDON, October 30 /PRNewswire/ -- London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, has entered an intensive partnering programme...

Clinical Genomics Continues Collaborative Research With CSIRO
7th October 2009 SYDNEY, October 7 /PRNewswire/ -- Sydney-based Clinical Genomics Pty Ltd and CSIRO have entered into a new phase in their collaboration to develop improved diagnostics for cancers of the colon and...

CSC and Cordys Establish Strategic Global Partnership
6th October 2009 PUTTEN, The Netherlands, and FALLS CHURCH, Virginia, October 6 /PRNewswire/ -- CSC (NYSE: CSC), a global leader in technology-enabled solutions and services, and Cordys, a leading provider of...

Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma
16th September 2009 DENVER, Colorado and JERUSALEM, September 16 /PRNewswire/ -- Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling patients for...

Helsinn Partners With Eisai for Gelclair in Italy
15th September 2009 LUGANO, Switzerland, September 15 /PRNewswire/ -- The Swiss pharmaceutical group Helsinn and Eisai Italy, subsidiary of the Japanese pharmaceutical company, have signed a licensing agreement for the...

Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.
15th September 2009 FREISING-WEIHENSTEPHAN, Germany, September 15 /PRNewswire/ -- Pieris AG today announced that they have entered into a collaboration agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris'...

Tosho's Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership
12th September 2009 BOZEN, Sud-Tyrol, Italy, September 12 /PRNewswire/ -- Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week...

Tosho's Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership
7th September 2009 BOZEN, Italy, September 7 /PRNewswire/ -- Health Robotics today announced that after a successful first year of cooperation in Japan with Tosho Inc., the companies signed this week a contract renewal...

Nucletron Increases Full Year Outlook After Strong First Half 2009
3rd September 2009 VEENENDAAL, the Netherlands, September 3 /PRNewswire/ -- Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009. Despite...

SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
1st September 2009 AMSTERDAM, September 1 /PRNewswire/ -- SynCo Bio Partners B.V., the expert in long term GMP contract manufacturing of biopharmaceuticals announced today that it has expanded its business into a new...

Team Garmin-Slipstream Announces POM Wonderful Sponsorship
31st August 2009 LOS ANGELES, August 31 /PRNewswire/ -- POM Wonderful, the largest U.S. grower of Wonderful variety pomegranates and maker of 100% pomegranate juice, today announced its sponsorship of...

Nuevolution Announces New Research Collaboration With Big Pharma
31st August 2009 COPENHAGEN, August 31 /PRNewswire/ -- Nuevolution A/S today announced that it has entered into a drug discovery collaboration with Novartis. During the collaboration, Nuevolution will apply...

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioPartnering America
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us